Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: Evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway

Glycobiology

Volumn 9, Issue 6, 1999, Pages 571-579

  Dricu, Anica ^a   Kanter, Lena ^a   Wang, Min ^a   Nilsson, Gunnar ^a   Hjertman, Magnus ^a   Wejde, Johan ^a   Larsson, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer cells; IGF 1 receptor; N linked glycosylation; Tunicamycin

Indexed keywords

ANTIBODY; CELL SURFACE RECEPTOR; DOLICHOL PHOSPHATE; ESTROGEN; ESTROGEN RECEPTOR; MEVALONIC ACID; SOMATOMEDIN C RECEPTOR;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RECEPTOR BINDING; SYNTHESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; DOLICHOL PHOSPHATES; GLYCOSYLATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUNICAMYCIN;

ANIMALIA;

EID: 0033012406     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/9.6.571     Document Type: Article

References (34)

1. Adair, W.L. and Keller, K. (1985) Isolation of dolichol and dolichyl phosphate. Methods Enzymol., 111, 201-215.
2. Arteaga, C.L., Kitten, L.J., Coronado, E.B., Jacobs, S. and Kull, F.C., Jr. (1989) Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. Clin. Invest., 84, 1418-1423.
3. Arteaga, C.L. (1992) Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res. Treat., 23, 101-106.
4. Baserga, R. (1995) The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res., 55, 249-252.
5. Belfiori, A., Constantino, A., Frasca, F., Pandini, G., Mineo, R., Vigneri, P., Maddux, B., Goldfine, I.D. and Vigneri, R. (1996) Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol. Endocrinol., 10, 1318-1326.
6. Carlberg, M. and Larsson, O. (1996) Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to the increased expression of IGF-1 receptors in human fibroblasts. Exp Cell Res., 223,142-148.
7. Carlberg, M., Dricu, A., Blegen, H., Wang, M., Hjertman, M., Zickert, P., Höög, A. and Larsson, O. (1996) Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. J. Biol. Chem., 271, 17453-17462.
8. Carson, D.D. and Lennarz, W.J. (1981)Relationship of dolichol synthesis to glycoprotein synthesis during embryonic development. J. Biol. Chem., 256, 4679-4686.
9. Constantino, A., Milazzo, G., Giorgino, F., Russo, P., Goldfine, I.D., Vigneri, R. and Belfiori, A. (1993) Insulin-resistent MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol. Endocrinol., 7, 1667-1676.
10. Dricu, A., Carlberg, M., Wang, M. and Larsson, O. (1997a) Inhibition of N-linked glycosylation using tunicamycin causes cell death in human malignant cells: role of down-regulation of the insulin-like growth factor-1 receptor in induction of apoptosis. Cancer Res., 57, 543-548.
11. Dricu, A., Wang, M., Hjertman, M., Malec, M., Blegen, H., Wejde, J., Carlberg, M. and Larsson, O. (1997b) Mevalonate-regulated cell growth in human tumor cells: role of glycosylation of the IGF-1 receptor, prenylation of Ras and expression of c-myc. Glycobiology, 7, 625-633.
12. Evan, G., Wyllie, A.H., Gilberts, C.S., Littlewood, T.D., Land, H., Brooks, M., Peen, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in ribroblasts by c-myc protein. Cell, 69, 119-128.
13. Gammeltoft, S. (1990) Peptide hormone action. A practical approach. In Siddle, K. and Hutton, J.C. (eds.), Peptide Receptors. Oxford University Press, Oxford, pp. 1-41.
14. Gammeltoft, S., Haselbacher, G.K., Humbel, R.E., Fehlmann, M. and Van Obberghen, E. (1985) Two types of receptors for insulin-like growth factors in mammalian brain. EMBO J., 4, 3407-3412.
15. Harrington, E.A., Bennet, M.R., Fanidi, A. and Evan, G.I. (1994) C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13, 3286-3290.
16. Hart, G.W. (1992) Glycosylation. Curr. Opin. Cell Biol., 4, 1017-1023.
17. Henry, A., Stacpoole, P.W. and Allen, C.M. (1991) Dolichol biosynthesis in human malignant cells. Biochem. J., 278, 741-747.
18. Huff, K.K., Kaufman, D., Gabbay, K.H., Spencer, E.M, Lippman, M.E. and Dickson, R.B. (1988a) Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res., 46, 4613-4619.
19. Huff, K.K., Knabbe, C., Lindsey, R., Kaufman, D., Bronzert, D., Lippman, M.E. and Dickson, R.B.(1988b) Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol. Endocrinol., 2, 200-208.
20. Kalebic, T., Tsokos, M. and Helman, L. (1994) In vivo treatment with antibody against the IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down regulates p34/cdc2. Cancer Res., 54, 5531-5534.
21. Kato, H., Faria, T.N., Stannard, B., Roberts, C.T., Jr. and LeRoith, D. (1993) Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-1 (IGF-1) receptor. Characterization of kinase-deficient IGF-1 receptors and the action of an IGF-1-mimetic antibody (αIR-3). J. Biol. Chem., 268, 2655-2661.
22. Laemmli, U.K. (1970) Most commonly used discontinuous buffer systems for SDS electrophoresis. Nature, 227, 680-685.
23. Massagué, J. and Czech, M.P. (1992) The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J. Biol. Chem., 257, 5038-5045.
24. Minuto, F., Del Monte, P., Barreca, A., Nicolin, A. and Giordano, G. (1987) Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. Mol. Cell. Endocrinol., 54, 179-184.
25. Peyrat, J.P. and Bonneterre, J. (1992) Type 1 IGF-1 receptor in human breast diseases. Breast Cancer Res. Treat., 22, 59-67.
26. Pietrzkowski, Z., Lammers, R., Carpenter, G., Soderquist, A.M., Limardo, M., Philiphs, P.D. and Baserga, R. (1992) Constitutive expression of IGF-1 and IGF-1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ., 3, 199-205.
27. Prager, D., Li, H.L., Asa, S. and Melmed, S. (1994) Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor mutant. Proc. Natl. Acad. Sci. USA, 91, 2181-2185.
28. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R. and Rubin, R. (1994) Rat glioblastoma cells expressing an antisense RNA to insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54, 2218-2222.
29. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P. and Baserga, R. (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55, 2463-2469.
30. Sell, C., Baserga, R. and Rubin, R. (1995) Insulin-like growth factor 1 (IGF-1) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Res., 55, 303-307.
31. Shapiro, D.N., Jones, B.G., Shapiro, L.H., Dias, P. and Houghton, P.J. (1994) Antisense-mediated reduction in insulin-like growth factor 1 receptor expression supresses the malignant phenotype of human alveolar rhabdomyosarcoma. J. Clin. Invest., 94, 1235-1242.
32. Sheeler, P. (1981) Centrifugation in Biology and Medical Science. Wiley, New York.
33. Steele-Perkins, G., Turner, J., Edman, J.C., Hari, J., Pierce, S.B., Stover.C., Rutter, W.J. and Roth, R.A. (1988) Expression and characterization of a functional human insulin-like growth factor 1 receptor. J. Biol. Chem., 263, 11486-11492.
34. Ullrich, A., Gray, A., Tam, A.W., Yang-Feneg, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J. and Fujita-Yamaguchi, Y. (1986) Insulin-like growth factor 1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5, 2503-2512.